These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
945 related articles for article (PubMed ID: 3925000)
1. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000 [TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Carrel S; Schmidt-Kessen A; Giuffrè L Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869 [TBL] [Abstract][Full Text] [Related]
3. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. Masuyama J; Minato N; Kano S J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562 [TBL] [Abstract][Full Text] [Related]
6. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon. Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657 [TBL] [Abstract][Full Text] [Related]
8. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795 [TBL] [Abstract][Full Text] [Related]
9. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. Geppert TD; Lipsky PE J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267 [TBL] [Abstract][Full Text] [Related]
10. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. Gonwa TA; Frost JP; Karr RW J Immunol; 1986 Jul; 137(2):519-24. PubMed ID: 3088102 [TBL] [Abstract][Full Text] [Related]
11. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Liversidge JM; Sewell HF; Forrester JV Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163 [TBL] [Abstract][Full Text] [Related]
12. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726 [TBL] [Abstract][Full Text] [Related]
13. Regulation of HLA class II antigen expression on cultured corneal epithelium by interferon-gamma. Iwata M; Kiritoshi A; Roat MI; Yagihashi A; Thoft RA Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2714-21. PubMed ID: 1639617 [TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986 [TBL] [Abstract][Full Text] [Related]
15. MHC antigen expression in human oral squamous carcinoma cell lines. Mutlu S; Matthews JB; Midda M; Scully C; Prime SS J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799 [TBL] [Abstract][Full Text] [Related]
16. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281 [TBL] [Abstract][Full Text] [Related]
17. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
18. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability. Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569 [TBL] [Abstract][Full Text] [Related]
19. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta. Shaw AR; Chan JK; Reid S; Seehafer J J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246 [TBL] [Abstract][Full Text] [Related]
20. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]